Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
37 Things Just Individuals Experiencing childhood during the 80s Will Comprehend - 2Best Augmented Simulation Ride: Which One Feels Generally Genuine?
- 3Artemis 2 moon rocket gets 'America 250' paint job | Space photo of the day for Dec. 23, 2025
- 4Vote In favor of Your Favored IT Administration
- 5A definitive Manual for Choosing Indoor Plants Ideal for Your Space
- Holiday season sees uptick in norovirus cases, according to CDC
- ACA subsidies latest: Making sense of what's happening with health care after Republicans revolt, forcing a vote on funding extension
- Top Frozen yogurt Flavor: Cast Your Vote!
- When Would it be a good idea for you to Look for Help from a Criminal Legal counselor?
- Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer's trials
- Most loved Occasion Dish: What Makes Your Merry Table?
- South Carolina's measles outbreak reaches 434 cases
- Manual for Financial plan Agreeable PC
- ChatGPT served as "suicide coach" in man's death, lawsuit alleges
